Grifols (GIKLY) Net Income towards Common Stockholders (QoQ) (2010 - 2020)

Grifols (GIKLY) Net Income towards Common Stockholders (QoQ) (2010 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -55.46%
Mar 31, 2019 -75.72%
Jun 30, 2018 -20.67%
Mar 31, 2018 -70.06%
Jun 30, 2017 2.91%
Mar 31, 2017 64.74%
Dec 31, 2016 -66.80%
Sep 30, 2016 123.48%
Jun 30, 2016 -38.01%
Mar 31, 2016 128.68%
Dec 31, 2015 -8.18%
Sep 30, 2015 105,910.32%
Jun 30, 2015 -99.90%
Sep 30, 2013 -6.88%
Jun 30, 2013 -0.24%
Mar 31, 2013 -18.93%
Dec 31, 2012 85.62%
Sep 30, 2012 -5.80%
Jun 30, 2012 -4.28%
Mar 31, 2012 908.68%